The progression-free survival (PFS) analysis revealed that the ALDH1A1 high expression group exhibited significantly lower PFS than the low expression group, both in lung cancer and colon cancer (Fig. 1A, D). Here, ALDH1A1 is linked to malignant colon neoplasm.